5 reasons to trust Clario with your eCOA Rescue Study
When the eCOA solution in your clinical trial is at risk, consider Clario’s experience in resetting studies across therapeutic areas and indications. Here are some qualities of our committed approach to helping studies revive and thrive.
01 Unique rescue methodology
Clario has developed a Playbook to rapidly engage with and manage each study, including:
This approach incorporates proven best practices from prior experiences. Learn about our rigorous model to build a tailored plan for your study.
02 Agile team focused on your study
We assign a project manager, solutions design analyst, technical implementation manager and scientist pre-award. This ‘triage team’ responds within 24 hours to arrange a current-state assessment. And we are prepared for the changes and fast-moving timelines associated with challenging trials.
03 A trusted partnership
Open and honest dialogue about every dimension of the trial turnaround.
Listen to our sponsor and CRO customers and partner with them to renew studies.
Anticipate possible obstacles and address every data, device and delivery inquiry with customer stakeholders.
04 Scientific and technical expertise
Our top priority is to deliver rich and compliant endpoint evidence to complete trials successfully. Specialists rally to support all phases of a study, the specific indication and the eCOA instruments used. For instance, a Clario data manager ensures the quality and regulatory readiness of patient endpoint data.
05 Worldwide presence and local know-how
Clario has expertise in staffing, logistics and translation around the globe, supporting multiple countries and thousands of patients. We have familiarity with the endpoint data standards of governing bodies in different countries, and senior resources based in Europe offer more time zone coverage.